GATA1 mutational analysis in chronic myeloid leukaemia.

GATA1 mutational analysis in chronic myeloid leukaemia.

Dettagli Bibliografici
Autori principali:	Halsey, C, Fisher, C, Strathdee, G, Gibson, B, Holyoake, T, Vyas, P, Graham, G
Natura:	Journal article
Lingua:	English
Pubblicazione:	2007

Documenti analoghi

Analysis of GATA-1 mutations in chronic myeloid leukaemia.
di: Halsey, C, et al.
Pubblicazione: (2006)

GATA1 and cooperating mutations in myeloid leukaemia of Down syndrome
di: Garnett, C, et al.
Pubblicazione: (2019)

How do Gata1 and cohesin gene mutations contribute to the development of myeloid leukaemia?
di: Garnett, C
Pubblicazione: (2020)

GATA1 Mutation In Transient Leukemia (TL) and Myeloid Leukemia of Down Syndrome
di: Reinhardt, K, et al.
Pubblicazione: (2010)

GATA1 Mutation In Transient Leukemia (TL) and Myeloid Leukemia of Down Syndrome
di: Reinhardt, K, et al.
Pubblicazione: (2010)

FLT3‐targeted therapy restores GATA1 pathway function in NPM1/FLT3‐ITD mutated acute myeloid leukaemia
di: D Sorcini, et al.
Pubblicazione: (2023-11-01)

Clonal structures of leukaemia stem cell populations in myeloid blast phase chronic myeloid leukaemia
di: Karamitros, D, et al.
Pubblicazione: (2016)

Analysis of GATA1 mutations in Down syndrome transient myeloproliferative disorder and myeloid leukemia.
di: Alford, K, et al.
Pubblicazione: (2011)

The Importance of Mutational Analysis in Chronic Myeloid Leukaemia for Treatment Choice
di: Hugues de Lavallade, et al.
Pubblicazione: (2016-11-01)

Natural history of GATA-1 mutations in Down syndrome.
di: Ahmed, M, et al.
Pubblicazione: (2003)

C/EBPalpha mutations in acute myeloid leukaemias.
di: Nerlov, C
Pubblicazione: (2004)

Natural history of GATA1 mutations in Down syndrome.
di: Ahmed, M, et al.
Pubblicazione: (2004)

Myelodysplastic syndrome due to somatic GATA1 mutation.
di: Freson, K, et al.
Pubblicazione: (2004)

miR-1202 acts as anti-oncomiR in myeloid leukaemia by down-modulating GATA-1S expression
di: Raffaele Sessa, et al.
Pubblicazione: (2024-02-01)

Abnormalities in the myeloid progenitor compartment in Down syndrome fetal liver precede acquisition of GATA1 mutations.
di: Tunstall-Pedoe, O, et al.
Pubblicazione: (2008)

Unprecedented behaviour of chronic myeloid leukaemia
di: Balambika RG, et al.
Pubblicazione: (2016-07-01)

Guidelines for the measurement of BCR-ABL1 transcripts in chronic myeloid leukaemia.
di: Foroni, L, et al.
Pubblicazione: (2011)

Chronic myeloid leukaemia with marked thrombocytosis
di: Jun Ooi, et al.
Pubblicazione: (2021-02-01)

Azacitidine for the treatment of myelodysplastic syndrome, chronic myelomonocytic leukaemia and acute myeloid leukaemia
di: R Edlin, et al.
Pubblicazione: (2010-05-01)

Azacitidine for the treatment of myelodysplastic syndrome, chronic myelomonocytic leukaemia and acute myeloid leukaemia
di: R Edlin, et al.
Pubblicazione: (2010-05-01)

GATA2 mutations and overexpression in pediatric acute myeloid leukemia
di: Zhenzhen Yang, et al.
Pubblicazione: (2019-08-01)

Acquired ASXL1 mutations are common in patients with inherited GATA2 mutations and correlate with myeloid transformation
di: Robert R. West, et al.
Pubblicazione: (2014-02-01)

A Myelodysplastic Syndrome Associated with a Clonal GATA1 Mutation.
di: Freson, K, et al.
Pubblicazione: (2008)

Transcriptional regulation of GATA1
di: Drissen, R, et al.
Pubblicazione: (2007)

Rapid parallel acquisition of somatic mutations after NPM1 in acute myeloid leukaemia evolution
di: Grove, C, et al.
Pubblicazione: (2016)

Low expression of the putative tumour suppressor gene gravin in chronic myeloid leukaemia, myelodysplastic syndromes and acute myeloid leukaemia.
di: Boultwood, J, et al.
Pubblicazione: (2004)

Slovenian recommendations for the management of chronic myeloid leukaemia
di: Irena Preložnik Zupan, et al.
Pubblicazione: (2018-04-01)

Two ophthalmic presentations of chronic myeloid leukaemia
di: Miles Kiernan, et al.
Pubblicazione: (2022-08-01)

Consensus on BCR-ABL1 reporting in chronic myeloid leukaemia in the UK
di: Cross, N, et al.
Pubblicazione: (2018)

EVI1 expression in acute myeloid leukaemia.
di: Langabeer, SE, et al.
Pubblicazione: (2001)

Deletion of the major GATA1 enhancer HS 1 does not affect eosinophil GATA1 expression and eosinophil differentiation.
di: Guyot, B, et al.
Pubblicazione: (2004)

PLATELET DYSFUNCTION AND MDS FEATURES DUE TO NOVEL SOMATIC GATA1 MUTATION
di: Freson, K, et al.
Pubblicazione: (2010)

Severe TMD/AMKL with GATA1 mutation in a stillborn fetus with Down syndrome.
di: Heald, B, et al.
Pubblicazione: (2007)

Harnessing the graft-versus-leukaemia effect in acute myeloid leukaemia
di: Sweeney, C
Pubblicazione: (2021)

GATA1-mediated megakaryocyte differentiation and growth control can be uncoupled and mapped to different domains in GATA1.
di: Kuhl, C, et al.
Pubblicazione: (2005)

Germline DNMT3A mutation in familial acute myeloid leukaemia
di: Courtney D. DiNardo, et al.
Pubblicazione: (2021-05-01)

Epigenetic Gene Mutations Impact on Outcome in Acute Myeloid Leukaemia
di: Christine S. Young, et al.
Pubblicazione: (2015-06-01)

A rare case of an elderly male with progression to chronic myeloid leukaemia secondary to chronic lymphocytic leukaemia
di: Sakditad Saowapa, et al.
Pubblicazione: (2024-03-01)

GATA1-mediated megakaryocyte differentiation and growth control can be uncoupled and mapped to different domains in GATA1
di: Kuhl, C, et al.
Pubblicazione: (2005)

The genetics of chronic myeloid leukaemia and recent advancements in therapy
di: Alexander Wellington
Pubblicazione: (2022-06-01)